Physician profile
June Peck
NPI 1649277682
$1,188.51
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,189.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $255.91 | 2021 | |
| Astellas Pharma US INC | $171.72 | 2021 | |
| Sanofi-Aventis U.S. LLC | $83.06 | 2021 | |
| Novo Nordisk INC | $76.08 | 2021 | |
| Amgen INC. | $65.41 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $58.62 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.96 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.22 | 2021 | |
| Esperion Therapeutics, INC. | $48.63 | 2021 | |
| Amarin Pharma, INC. | $37.88 | 2021 | |
| Glaxosmithkline, LLC. | $29.17 | 2021 | |
| Nestle Healthcare Nutrition INC. | $29.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.91 | 2021 | |
| Lilly USA, LLC | $25.31 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $24.09 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.19 | 2021 | |
| Clarus Therapeutics INC. | $14.69 | 2021 | |
| Currax Pharmaceuticals LLC | $12.66 | 2021 | |
| Eisai INC. | $12.02 | 2021 | |
| Sunovion Pharmaceuticals INC. | $11.97 | 2021 | |
| Merck Sharp & Dohme LLC | $11.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.18 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw June Peck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.